We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$298B
AUM Growth
+$23.2B
Cap. Flow
+$26.9B
Cap. Flow %
9.01%
Top 10 Hldgs %
23.64%
Holding
11,380
New
1,223
Increased
4,885
Reduced
3,876
Closed
1,294

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.58B
2
NFLX icon
Netflix
NFLX
+$496M
3
META icon
Meta Platforms (Facebook)
META
+$275M
4
BABA icon
Alibaba
BABA
+$215M
5
UNH icon
UnitedHealth
UNH
+$189M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.18%
2 Technology 2.09%
3 Communication Services 1.44%
4 Financials 1.21%
5 Healthcare 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SB icon
9901
CALL
Safe Bulkers
SB
$886M
$21K ﹤0.01%
+12,000
New +$23.4K
SER icon
9902
Serina Therapeutics
SER
$68.6M
$21K ﹤0.01%
302
-321
-52% -$30.4K
STAB
9903
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$21K ﹤0.01%
+21,043
New +$28.4K
CSLT
9904
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$21K ﹤0.01%
15,000
-3,700
-20% -$7.38K
CVIA
9905
CALL
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$21K ﹤0.01%
10,400
-3,900
-27% -$7.24K
FWP
9906
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$21K ﹤0.01%
3,001
+109
+4% +$725
ABUS icon
9907
Arbutus Biopharma
ABUS
$1.03B
$20K ﹤0.01%
12,981
-27,617
-68% -$47.6K
DLNG icon
9908
PUT
Dynagas LNG Partners
DLNG
$135M
$20K ﹤0.01%
10,200
-64,600
-86% -$88.6K
DXF
9909
Eason Technology Ltd
DXF
$1.68M
$20K ﹤0.01%
+13
New +$28.7K
TARA icon
9910
Protara Therapeutics
TARA
$235M
$20K ﹤0.01%
+1,901
New +$27.2K
XBIO icon
9911
Xenetic Biosciences
XBIO
$8.95M
$20K ﹤0.01%
+1,690
New +$60.4K
VIRX
9912
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$20K ﹤0.01%
+809
New +$23.3K
RTW
9913
DELISTED
RTW Retailwinds, Inc.
RTW
$20K ﹤0.01%
14,414
-847
-6% -$1.32K
ROAN
9914
DELISTED
Roan Resources, Inc.
ROAN
$20K ﹤0.01%
16,175
-158,170
-91% -$206K
YDKG
9915
Yueda Digital Holding
YDKG
$5.81M
$19K ﹤0.01%
49
-12
-20% -$5.64K
ENVB icon
9916
Enveric Biosciences
ENVB
$6.53M
0
PHUN icon
9917
Phunware
PHUN
$44M
$19K ﹤0.01%
+257
New +$22.4K
SXTC icon
9918
China SXT Pharmaceuticals
SXTC
$1.91M
0
STCN
9919
DELISTED
Steel Connect, Inc. Common Stock
STCN
$19K ﹤0.01%
+1,165
New +$19.2K
FPAYW
9920
DELISTED
FlexShopper, Inc. Warrants
FPAYW
$19K ﹤0.01%
40,619
+27,548
+211% +$16.5K
BKYI
9921
BIO-key International
BKYI
$4.34M
$18K ﹤0.01%
21
+14
+200% +$19.2K
CPSH icon
9922
CPS Technologies
CPSH
$77.9M
$18K ﹤0.01%
17,700
-9,666
-35% -$9.97K
LCTX icon
9923
CALL
Lineage Cell Therapeutics
LCTX
$286M
$18K ﹤0.01%
18,800
+3,000
+19% +$3.11K
PZG icon
9924
Paramount Gold Nevada
PZG
$133M
$18K ﹤0.01%
+26,850
New +$23.1K
BLNKW
9925
DELISTED
Blink Charging Co. Warrant
BLNKW
$18K ﹤0.01%
39,919
-32,914
-45% -$16.8K

Similar funds

Jeff Yass's Q3 2019 Portfolio in Review

As of Q3 2019, Jeff Yass held 11,380 positions worth $298B, up 8.4% from $275B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $26.9B of net new capital in Q3 2019, opening 1,223 new positions and adding to 4,885 existing holdings. Its largest new stake was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 1.8% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $926M trimmed.

  • Jeff Yass's largest Q3 2019 buy was iShares US Treasury Bond ETF: 2,524,484 shares worth $66.5M.
  • Jeff Yass added most to Amazon in Q3 2019, an estimated $1.58B increase.
  • Jeff Yass's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $926M.
  • Jeff Yass fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $179M.
  • Jeff Yass's ten largest holdings make up 24% of its $298B portfolio in Q3 2019.
  • Jeff Yass opened 1,223 new positions and closed 1,294 in Q3 2019.
  • Jeff Yass's portfolio value rose 8.4% quarter-over-quarter to $298B.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.